Rakovina Therapeutics Announces Final Closing of Upsized Non-Brokered Private Placement
Financing completed at the full upsized amount following strong investor demand VANCOUVER, British Columbia, Aug.
31, 2026 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO0), a biopharmaceutical compa
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.